Novo Nordisk A/S stock price
NVO
#61

₺2.031,89
  

1.5%

Novo Nordisk A/S Info

Piyasa değ.
₺9T

1.5%

Günlük Hacim
₺21,08B
Varlık türü
Hisse S.
Çalışanlar
78387
Kuruluş
Dec 21, 1923
Temel borsa
New York Stock Exchange
CIK numarası
0000353278

Tokenize Hisse Verileri

Ort. Tokenize Fiyat
₺2,06K
Fiyat Farkı
+₺36,26(+1.78%)
Tokenize Piy. Değ.
₺165,25M

1.16%

Tokenize Hac. (24s)
₺46,6M

2.32%

İhraççı
Sözleşmeler
Gezginler
NVO/USD Dönüştürücü
NVO
TRY
Fiyat performansı
Düşük
₺2K
Yüksek
₺2,07K

Veriler Yükleniyor

Grafik verilerini yüklüyoruz, lütfen bekleyin

Novo Nordisk A/S topluluğu

skeleton-white
 
 
 
 
 
 

About Novo Nordisk A/S

What is Novo Nordisk A/S?

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

Novo Nordisk A/S Fiyatı Canlı Veri

The current price of Novo Nordisk A/S in the market is ₺2.031,89, with a 24-hour trading volume of ₺21,08B. The asset's market cap is ₺9T, after moving -1.51% in the last day.

Tokenized Novo Nordisk A/S is trading at ₺2.068,15, with a tokenized market cap of ₺165,25M and a 24-hour trading volume of ₺46,6M. The tokenized asset has moved -1.16% in the past 24 hours.